| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RAB5B, member RAS oncogene family | 0.722 | 0.346 | 2.6E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protocadherin alpha 6 | 0.931 | 0.115 | 3.6E-11 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protocadherin alpha 7 | 1.000 | 0.077 | 5.0E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protocadherin alpha 8 | 0.931 | 0.077 | 1.3E-18 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protocadherin alpha 10 | 4.1E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||||
|
protocadherin alpha 11 | 5.5E-17 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||||
|
protocadherin alpha 12 | 2.4E-13 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||||
|
protocadherin alpha 13 | 0.931 | 0.077 | 2.4E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
mitogen-activated protein kinase 4 | 0.821 | 0.231 | 0.22 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
transcriptional regulating factor 1 | 0.729 | 0.346 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
exocyst complex component 2 | 0.751 | 0.423 | 2.9E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
phosphatidylinositol glycan anchor biosynthesis class V | 0.636 | 0.615 | 1.5E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
chromodomain helicase DNA binding protein 7 | 0.441 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 3 | 2016 | 2016 | ||||||||
|
MIR3936 host gene | 0.861 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
proton activated chloride channel 1 | 0.565 | 0.731 | 5.4E-10 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protocadherin alpha 5 | 0.931 | 0.115 | 5.8E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protocadherin alpha 4 | 0.839 | 0.115 | 2.0E-23 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protocadherin alpha 3 | 0.861 | 0.192 | 8.4E-16 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
Pvt1 oncogene | 0.495 | 0.731 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protein tyrosine phosphatase receptor type C | 0.435 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
BCL2 antagonist/killer 1 | 0.555 | 0.769 | 7.4E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
microtubule affinity regulating kinase 4 | 0.641 | 0.615 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | ||||||||
|
component of oligomeric golgi complex 6 | 0.644 | 0.577 | 6.4E-16 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
rhomboid domain containing 2 | 0.839 | 0.115 | 0.64 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 |